×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 5: Stakeholder & Patient Engagement
Session Chair(s)
Marjon Pasmooij, PhD
Head Science Department / Associate Professor of Drug Regulatory Science
Dutch Medicines Evaluation Board / Utrecht University, Netherlands
Session 5: Stakeholder & Patient Engagement
Speaker(s)
Patient Involvement in Regulatory Procedures and Impact on Regulatory Decision Making
Sharon L Gorman
Pfizer, Inc., United Kingdom
Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-Making
Robbe Saesen
KU Leuven, Belgium
PhD Researcher
Stakeholder Perspectives on Implementing Precision Medicine in Diabetic Kidney Disease
Elisabeth Bakker
University Medical Centre Groningen, Netherlands
PhD Student, Clinical Pharmacy and Pharmacology
Study to support the evaluation of the EU Orphan Regulation
Thyra de Jongh
Technopolis Group, Netherlands
Principal Consultant
Have an account?